Evaluating Clinical Outcomes and Adverse Events: Risk Stratification of EUS-Guided Through-the-Needle Biopsy for Pancreatic Cyst in a Large Cohort

Key Points

• EUS-TTNB shows notable clinical utility for revising diagnoses in patients with pancreatic cysts, enhancing treatment decisions.
• The risk stratification model categorizes potential adverse events, indicating a need for careful patient selection during procedures.
• Analysis of large cohort data underscores the importance of assessing risks alongside clinical outcomes in EUS-TTNB applications.
• Enhanced patient selection criteria may improve safety and efficacy but necessitates further evaluations to confirm findings.

Abstract